Inovio Product Pipeline: Biodefense DNA Vaccines

Product & Indication
Intramuscular delivery of selected bio-warfare antigens using Inovio's electroporation technology.
Worked being conducted by the US Army is funded by the US Department of Defense.

Market Potential
TBD

Stage of Development
Phase: Pre-clinical product definition.
Purpose: Define clinical candidates.

Commercialization
Vaccine: owned by US Army.
Delivery technology: owned by Inovio.